The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 5, 2026 | Williams Eugene | Director | Buy(P) | 2K | $24.40 | $49K |
| Mar 4, 2026 | Williams Eugene | Director | Buy(P) | 2K | $24.00 | $48K |
| Mar 3, 2026 | Williams Eugene | Director | Buy(P) | 1K | $21.89 | $22K |
| Mar 2, 2026 | Williams Eugene | Director | Buy(P) | 1K | $22.53 | $23K |
| Feb 19, 2026 | Kaplan Johanne | Chief Development Officer | Buy(P) | 2K | $15.35 | $25K |
| Feb 3, 2026 | Kirwin Patrick D. | Director | Grant(A) | 3K | $12.13 | $37K |
| Feb 3, 2026 | Kirwin Patrick D. | Director | Grant(A) | 3K | — | — |
| Feb 3, 2026 | Milbury Max A. | Insider | Grant(A) | 7K | $12.13 | $80K |
| Feb 3, 2026 | Milbury Max A. | Insider | Grant(A) | 7K | — | — |
| Feb 3, 2026 | Warma Neil K | Chief Executive Officer, Director | Grant(A) | 6K | $12.13 | $75K |
| Feb 3, 2026 | Warma Neil K | Chief Executive Officer, Director | Grant(A) | 6K | — | — |
| Feb 3, 2026 | Kaplan Johanne | Chief Development Officer | Grant(A) | 2K | $12.13 | $25K |
| Feb 3, 2026 | Kaplan Johanne | Chief Development Officer | Grant(A) | 2K | — | — |
| Feb 3, 2026 | Cashman Neil | Chief Scientific Officer, Director | Grant(A) | 4K | $12.13 | $50K |
| Feb 3, 2026 | Cashman Neil | Chief Scientific Officer, Director | Grant(A) | 4K | — | — |
| Feb 3, 2026 | Yu Fan | 10% Owner | Buy(P) | 701K | $12.13 | $8.5M |
| Feb 3, 2026 | Yu Fan | 10% Owner | Buy(P) | 701K | — | — |
| Oct 22, 2025 | Alex Slanix Paul | Director | Grant(A) | 40K | — | $0 |
| Oct 3, 2025 | Milbury Max A. | Insider | Buy(P) | 30K | $0.49 | $15K |
| Sep 22, 2025 | Warma Neil K | Chief Executive Officer, Director | Grant(A) | 600K | — | $0 |
| Sep 22, 2025 | Altstiel Larry Douglas | Chief Medical Officer | Grant(A) | 165K | — | $0 |
| Sep 22, 2025 | Milbury Max A. | Insider | Grant(A) | 60K | — | $0 |
| Sep 22, 2025 | Cashman Neil | Chief Scientific Officer, Director | Grant(A) | 165K | — | $0 |
| Sep 22, 2025 | Kaplan Johanne | Chief Development Officer | Grant(A) | 165K | — | $0 |
| Jul 29, 2025 | Sclar Jeremy M. | 10% Owner | Buy(P) | 3.1M | — | — |
| Jul 29, 2025 | Jeremy M. Sclar 2012 Irrevocable Family Trust | 10% Owner | Buy(P) | 3.1M | — | — |
| Jul 25, 2025 | Gordon Michael S | Insider | Option exercise(X) | 120K | — | $0 |
| Jul 25, 2025 | Gordon Michael S | Insider | Option exercise(X) | 120K | — | $0 |
| Jul 25, 2025 | Gordon Michael S | Insider | Option exercise(X) | 120K | — | $0 |
| Jul 25, 2025 | Title 19 Promis | Insider | Option exercise(X) | 120K | — | $0 |
| Jul 25, 2025 | Title 19 Promis | Insider | Option exercise(X) | 120K | — | $0 |
| Jul 25, 2025 | Title 19 Promis | Insider | Option exercise(X) | 120K | — | $0 |
| Jul 25, 2025 | Sclar Jeremy M. | 10% Owner | Option exercise(X) | 698K | — | — |
| Jul 25, 2025 | Sclar Jeremy M. | 10% Owner | Option exercise(X) | 698K | — | — |
| Jul 25, 2025 | Sclar Jeremy M. | 10% Owner | Option exercise(X) | 698K | — | — |
| Jul 25, 2025 | Sclar Jeremy M. | 10% Owner | Option exercise(X) | 698K | — | $0 |
| Jul 25, 2025 | Sclar Jeremy M. | 10% Owner | Option exercise(X) | 698K | — | $0 |
| Jul 25, 2025 | Sclar Jeremy M. | 10% Owner | Option exercise(X) | 698K | — | $0 |
| Jul 25, 2025 | Jeremy M. Sclar 2012 Irrevocable Family Trust | 10% Owner | Option exercise(X) | 698K | — | — |
| Jul 25, 2025 | Jeremy M. Sclar 2012 Irrevocable Family Trust | 10% Owner | Option exercise(X) | 698K | — | — |
| Jul 25, 2025 | Jeremy M. Sclar 2012 Irrevocable Family Trust | 10% Owner | Option exercise(X) | 698K | — | — |
| Jul 25, 2025 | Jeremy M. Sclar 2012 Irrevocable Family Trust | 10% Owner | Option exercise(X) | 698K | — | $0 |
| Jul 25, 2025 | Jeremy M. Sclar 2012 Irrevocable Family Trust | 10% Owner | Option exercise(X) | 698K | — | $0 |
| Jul 25, 2025 | Jeremy M. Sclar 2012 Irrevocable Family Trust | 10% Owner | Option exercise(X) | 698K | — | $0 |
| Jun 30, 2025 | Gordon Michael S | 10% Owner | Sell(S) | 93K | — | — |
| Jun 12, 2025 | Williams Eugene | Director | Grant(A) | 20K | — | $0 |
| Jun 12, 2025 | Wyman William W | Director | Grant(A) | 20K | — | $0 |
| Jun 12, 2025 | Shafmaster Madge K. | Director | Grant(A) | 20K | — | $0 |
| Jun 12, 2025 | Kirwin Patrick D. | Director | Grant(A) | 20K | — | $0 |
| Jun 12, 2025 | Mandel-Brehm Josh | Director | Grant(A) | 20K | — | $0 |
| Mar 13, 2025 | Gordon Michael S | Insider | Other(J) | 48K | — | — |
| Feb 10, 2025 | Cashman Neil | Chief Scientific Officer, Director | Buy(P) | 15K | $0.97 | $15K |
| Nov 18, 2024 | Altstiel Larry Douglas | Chief Medical Officer | Grant(A) | 175K | — | $0 |
| Nov 18, 2024 | Cashman Neil | Chief Scientific Officer, Director | Grant(A) | 200K | — | $0 |
| Nov 18, 2024 | Kaplan Johanne | Chief Development Officer | Grant(A) | 175K | — | $0 |
| Nov 18, 2024 | Milbury Max A. | Principal Accounting Officer | Grant(A) | 70K | — | $0 |
| Oct 8, 2024 | Warma Neil K | Chief Executive Officer | Grant(A) | 490K | — | $0 |
| Oct 8, 2024 | Warma Neil K | Chief Executive Officer | Grant(A) | 1.1M | — | $0 |
| Oct 3, 2024 | Kirwin Patrick D. | Director | Grant(A) | 40K | — | $0 |
| Oct 3, 2024 | Mandel-Brehm Josh | Director | Grant(A) | 40K | — | $0 |
| Oct 3, 2024 | Shafmaster Madge K. | Director | Grant(A) | 40K | — | $0 |
| Oct 3, 2024 | Williams Eugene | Director | Grant(A) | 40K | — | $0 |
| Oct 3, 2024 | Wyman William W | Director | Grant(A) | 40K | — | $0 |
| Sep 24, 2024 | Shafmaster Madge K. | Director | Buy(P) | 70K | $1.30 | $91K |
| Sep 23, 2024 | Shafmaster Madge K. | Director | Buy(P) | 70K | $1.28 | $90K |
| Sep 20, 2024 | Shafmaster Madge K. | Director | Buy(P) | 60K | $1.25 | $75K |
| Sep 17, 2024 | Gordon Michael S | 10% Owner | Buy(P) | 16K | $1.40 | $23K |
| Sep 16, 2024 | Gordon Michael S | 10% Owner | Buy(P) | 77K | $1.22 | $94K |
| Aug 14, 2024 | Kirwin Patrick D. | Director | Buy(P) | 10K | $1.25 | $13K |
| Jul 31, 2024 | Sclar Jeremy M. | 10% Owner | Conversion(C) | 150K | — | — |
| Jul 31, 2024 | Sclar Jeremy M. | 10% Owner | Buy(P) | 698K | — | — |
| Jul 31, 2024 | Sclar Jeremy M. | 10% Owner | Conversion(C) | 150K | — | — |
| Jul 31, 2024 | Sclar Jeremy M. | 10% Owner | Buy(P) | 698K | — | — |
| Jul 31, 2024 | Sclar Jeremy M. | 10% Owner | Buy(P) | 698K | — | — |
| Jul 31, 2024 | Sclar Jeremy M. | 10% Owner | Buy(P) | 698K | — | — |
| Jul 31, 2024 | Sclar Jeremy M. | 10% Owner | Conversion(C) | 150K | — | — |
| Jul 31, 2024 | Sclar Jeremy M. | 10% Owner | Conversion(C) | 150K | — | — |
| Jul 31, 2024 | Gordon Michael S | 10% Owner | Buy(P) | 465K | — | — |
| Jul 31, 2024 | Gordon Michael S | 10% Owner | Conversion(C) | 500K | — | — |
| Jul 31, 2024 | Gordon Michael S | 10% Owner | Buy(P) | 465K | — | — |
| Jul 31, 2024 | Gordon Michael S | 10% Owner | Buy(P) | 465K | — | — |
| Jul 31, 2024 | Gordon Michael S | 10% Owner | Buy(P) | 465K | — | — |
| Jul 31, 2024 | Gordon Michael S | 10% Owner | Conversion(C) | 500K | — | — |
| Jul 31, 2024 | Title 19 Promis | 10% Owner | Conversion(C) | 500K | — | — |
| Jul 31, 2024 | Title 19 Promis | 10% Owner | Buy(P) | 465K | — | — |
| Jul 31, 2024 | Title 19 Promis | 10% Owner | Buy(P) | 465K | — | — |
| Jul 31, 2024 | Title 19 Promis | 10% Owner | Conversion(C) | 500K | — | — |
| Jul 31, 2024 | Title 19 Promis | 10% Owner | Buy(P) | 465K | — | — |
| Jul 31, 2024 | Title 19 Promis | 10% Owner | Buy(P) | 465K | — | — |
| Jan 2, 2024 | Warma Neil K | Chief Executive Officer | Grant(A) | 200K | — | $0 |
| Dec 4, 2023 | Sclar Jeremy M. | 10% Owner | Sell(S) | 150K | — | — |
| Dec 4, 2023 | Sclar Jeremy M. | 10% Owner | Buy(P) | 150K | — | — |
| Dec 4, 2023 | Sclar Jeremy M. | 10% Owner | Sell(S) | 150K | — | — |
| Dec 4, 2023 | Sclar Jeremy M. | 10% Owner | Buy(P) | 150K | — | — |
| Oct 26, 2023 | Malenfant Gavin T. | Chief Operating Officer, Director | Grant(A) | 13K | — | $0 |
| Oct 26, 2023 | Kaplan Johanne | Chief Development Officer | Grant(A) | 13K | — | $0 |
| Oct 26, 2023 | Geffken Daniel E. | Chief Financial Officer | Grant(A) | 3K | — | $0 |
| Oct 26, 2023 | Cashman Neil | Chief Scientific Officer, Director | Grant(A) | 13K | — | $0 |
| Oct 26, 2023 | Milbury Max A. | Principal Accounting Officer | Grant(A) | 13K | — | $0 |
| Oct 26, 2023 | Altstiel Larry Douglas | Chief Medical Officer | Grant(A) | 13K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).